Microdialysis of skeletal muscle at rest.
Techniques in human skeletal muscle research are by necessity predominantly 'descriptive'. Microdialysis has raised high expectations that it could meet the demand for a method that allows 'mechanistic' investigations to be performed in human skeletal muscle. In the present review, some views are given on how well the initial expectations on the use of the microdialysis technique in skeletal muscle have been fulfilled, and the areas in which additional work is needed in order to validate microdialysis as an important metabolic technique in this tissue. The microdialysis catheter has been equated to an artificial blood vessel, which is introduced into the tissue. By means of this 'vessel' the concentrations of compounds in the interstitial space can be monitored. The concentration of substances in the collected samples is dependent on the rate of perfusate flow. When perfusate flow is slow enough to allow complete equilibration between interstitial and perfusate fluids, the concentration in the perfusate is maximal and identical to the interstitial concentration. Microdialysis data may be influenced by changes in blood flow, especially in instances where the tissue diffusivity limits the recovery in vivo, i.e. when recovery in vitro is 100%, whereas the recovery in vivo is less than 100%. Microdialysis data indicate that a significant arterial-interstitial glucose concentration gradient exists in skeletal muscle but not in adipose tissue at rest. While the concentrations of glucose and lactate in the dialysate from skeletal muscle are close to the expected values, the glycerol values obtained for muscle are still puzzling. Ethanol added to the perfusate will be cleared by the tissue at a rate that is determined by the nutritive blood flow (the microdialysis ethanol technique). It is concluded that microdialysis of skeletal muscle has become an important technique for mechanistic studies in human metabolism and nutrition.
Henriksson
J
J
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. jan.henriksson@fyfa.ki.se
D001783:Blood Flow Velocity; D005110:Extracellular Space / Q000378:metabolism; D006801:Humans; D017551:Microdialysis; D018482:Muscle, Skeletal / Q000098:blood supply / Q000378:metabolism*; D009747:Nutritional Physiological Phenomena; D012146:Rest